International Infusion is a venture capital firm that specializes in investing in disruptive technologies within the life sciences sector and renewable energy industries, as well as other emerging areas of innovation. Operating since its foundation in 2009, the firm is headquartered in Chicago, Illinois. The investment thesis of International Infusion centers around identifying and supporting startups and companies that are pioneering significant advancements and can demonstrate a clear potential to transform markets and improve lives. They focus on seeking out opportunities that are not only commercially viable but also have the prospect to leave a positive impact on society and the environment. In the life sciences realm, they look for companies that are working on groundbreaking treatments, innovative medical devices, and cutting-edge research tools. In the field of renewable energy, their interest lies in technologies that promise cleaner, more efficient, and sustainable sources of energy. Beyond these two core areas, International Infusion also explores investments in other high-growth industries where technology can be a catalyst for change. They aim to partner with entrepreneurs who have a deep understanding of their market and the tenacity to solve complex challenges. The firm brings not just capital, but also strategic support to their portfolio companies, assisting with everything from operations to scaling and exit strategies. International Infusion is known for their commitment to collaborate closely with founders to realize their vision and achieve long-term success.